IDH1 and central nervous system cancer: IDH mutant gliomas are more sensitive to radiotherapy, as they have reduced levels of Nicotinamide Adenine Dinucleotide (NADH) and Nicotinamide Adenine Dinucleotide Phosphate (NADPH) to resist oxidative stress responses (Molenaar et al., 2015).